Comparing Message-Based Psychotherapy to Once-Weekly, Video-Based Psychotherapy for Moderate Depression: Randomized Controlled Trial.

Burden of Disease anxiety depression functional impairment, credibility, alliance, engagement intervention mental health message therapy message-based psychotherapy randomized controlled trial telehealth telemedicine text mining video-based psychotherapy

Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
29 06 2023
Historique:
received: 27 01 2023
accepted: 23 05 2023
revised: 03 05 2023
medline: 3 7 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: epublish

Résumé

Despite the high prevalence of major depressive disorder and the related societal burden, access to effective traditional face-to-face or video-based psychotherapy is a challenge. An alternative that offers mental health care in a flexible setting is asynchronous messaging therapy. To date, no study has evaluated its efficacy and acceptability in a randomized controlled trial for depression. The aim of this study was to compare the efficacy and acceptability of message-based psychotherapy for depression to once-weekly video-based psychotherapy. In this 2-armed randomized controlled trial, individuals (N=83) with depressive symptomatology (Patient Health Questionnaire-9 ≥10) were recruited on the internet and randomly assigned to either a message-based intervention group (n=46) or a once-weekly video-based intervention group (n=37). Patients in the message-based treatment condition exchanged asynchronous messages with their therapist following an agreed-upon schedule. Patients in the video-based treatment condition met with their therapist once each week for a 45-minute video teletherapy session. Self-report data for depression, anxiety, and functional impairment were collected at pretreatment, weekly during treatment, at posttreatment, and at a 6-month follow-up. Self-reported treatment expectancy and credibility for the assigned intervention were assessed at pretreatment and therapeutic alliance at posttreatment. Findings from multilevel modeling indicated significant, medium-to-large improvements in depression (d=1.04; 95% CI 0.60-1.46), anxiety (d=0.61; 95% CI 0.22-0.99), and functional impairment (d=0.66; 95% CI 0.27-1.05) for patients in the message-based treatment condition. Changes in depression (d=0.11; 95% CI -0.43 to 0.66), anxiety (d=-0.01; 95% CI -0.56 to 0.53), and functional impairment (d=0.25; 95% CI -0.30 to 0.80) in the message-based treatment condition were noninferior to those in the video-based treatment condition. There were no significant differences in treatment credibility (d=-0.09; 95% CI -0.64 to 0.45), therapeutic alliance (d=-0.15; 95% CI -0.75 to 0.44), or engagement (d=0.24; 95% CI -0.20 to 0.67) between the 2 treatment conditions. Message-based psychotherapy could present an effective and accessible alternative treatment modality for patients who might not be able to engage in traditional scheduled services such as face-to-face or video-based psychotherapy. ClinicalTrials.gov NCT05467787; https://www.clinicaltrials.gov/ct2/show/NCT05467787.

Sections du résumé

BACKGROUND
Despite the high prevalence of major depressive disorder and the related societal burden, access to effective traditional face-to-face or video-based psychotherapy is a challenge. An alternative that offers mental health care in a flexible setting is asynchronous messaging therapy. To date, no study has evaluated its efficacy and acceptability in a randomized controlled trial for depression.
OBJECTIVE
The aim of this study was to compare the efficacy and acceptability of message-based psychotherapy for depression to once-weekly video-based psychotherapy.
METHODS
In this 2-armed randomized controlled trial, individuals (N=83) with depressive symptomatology (Patient Health Questionnaire-9 ≥10) were recruited on the internet and randomly assigned to either a message-based intervention group (n=46) or a once-weekly video-based intervention group (n=37). Patients in the message-based treatment condition exchanged asynchronous messages with their therapist following an agreed-upon schedule. Patients in the video-based treatment condition met with their therapist once each week for a 45-minute video teletherapy session. Self-report data for depression, anxiety, and functional impairment were collected at pretreatment, weekly during treatment, at posttreatment, and at a 6-month follow-up. Self-reported treatment expectancy and credibility for the assigned intervention were assessed at pretreatment and therapeutic alliance at posttreatment.
RESULTS
Findings from multilevel modeling indicated significant, medium-to-large improvements in depression (d=1.04; 95% CI 0.60-1.46), anxiety (d=0.61; 95% CI 0.22-0.99), and functional impairment (d=0.66; 95% CI 0.27-1.05) for patients in the message-based treatment condition. Changes in depression (d=0.11; 95% CI -0.43 to 0.66), anxiety (d=-0.01; 95% CI -0.56 to 0.53), and functional impairment (d=0.25; 95% CI -0.30 to 0.80) in the message-based treatment condition were noninferior to those in the video-based treatment condition. There were no significant differences in treatment credibility (d=-0.09; 95% CI -0.64 to 0.45), therapeutic alliance (d=-0.15; 95% CI -0.75 to 0.44), or engagement (d=0.24; 95% CI -0.20 to 0.67) between the 2 treatment conditions.
CONCLUSIONS
Message-based psychotherapy could present an effective and accessible alternative treatment modality for patients who might not be able to engage in traditional scheduled services such as face-to-face or video-based psychotherapy.
TRIAL REGISTRATION
ClinicalTrials.gov NCT05467787; https://www.clinicaltrials.gov/ct2/show/NCT05467787.

Identifiants

pubmed: 37384392
pii: v25i1e46052
doi: 10.2196/46052
pmc: PMC10365600
doi:

Banques de données

ClinicalTrials.gov
['NCT05467787']

Types de publication

Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e46052

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States

Informations de copyright

©Jiyoung Song, Boris Litvin, Ryan Allred, Shiyu Chen, Thomas D Hull, Patricia A Areán. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 29.06.2023.

Références

NPJ Digit Med. 2019 Jun 17;2:54
pubmed: 31304400
J Clin Psychol. 1986 Jul;42(4):562-9
pubmed: 3745453
Cyberpsychol Behav Soc Netw. 2013 May;16(5):370-7
pubmed: 23530546
J Anxiety Disord. 1997 May-Jun;11(3):221-40
pubmed: 9220298
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Health Aff (Millwood). 2018 Dec;37(12):1975-1982
pubmed: 30633674
Telemed J E Health. 2017 Mar;23(3):240-247
pubmed: 27797646
J Clin Transl Sci. 2020 May 04;4(5):463-467
pubmed: 33244437
Curr Psychiatry Rep. 2018 Aug 28;20(10):85
pubmed: 30155593
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
BMC Psychiatry. 2020 Jun 12;20(1):297
pubmed: 32532225
Clin Psychol Rev. 2020 Dec;82:101921
pubmed: 33069096
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Clin Psychol Psychother. 2010 May-Jun;17(3):231-9
pubmed: 20013760
Clin Psychol Rev. 2015 Aug;40:57-65
pubmed: 26067572
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
JAMA Netw Open. 2020 Sep 1;3(9):e2019686
pubmed: 32876685
J Consult Clin Psychol. 1977 Dec;45(6):1052-9
pubmed: 21894
Front Digit Health. 2022 Feb 10;4:840169
pubmed: 35224537
Clin Orthop Surg. 2014 Mar;6(1):103-9
pubmed: 24605197
MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):306-312
pubmed: 35202357
J Affect Disord. 2021 Jan 1;278:131-135
pubmed: 32956962
J Consult Clin Psychol. 1993 Aug;61(4):611-9
pubmed: 8370856
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
BMJ Open. 2021 Nov 2;11(11):e046958
pubmed: 34728440
JMIR Ment Health. 2015 Mar 16;2(1):e4
pubmed: 26543910
Am Psychol. 2021 Jan;76(1):14-25
pubmed: 32816503

Auteurs

Jiyoung Song (J)

Department of Psychology, University of California, Berkeley, Berkeley, CA, United States.

Boris Litvin (B)

Talkspace, New York, NY, United States.

Ryan Allred (R)

Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States.

Shiyu Chen (S)

Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States.

Thomas D Hull (TD)

Talkspace, New York, NY, United States.

Patricia A Areán (PA)

Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH